Exosomes derived from tumor cells can directly enter CD8+ T cells, tumor-infiltrating T lymphocytes (TILs), or regulatory T cells (Tregs), leading to inhibition of their anti-tumor function or modulation of their cellular behaviors [67,68,69]. Here, CD8A is linked to neoplasm.